Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...

The scientists also showed that, among other things, NOTCH enables the action of ... in the CD8 + T cell response, but very little was known about the underlying mechanism," said Labrecque ...

Building on the lessons learned from the development of the first-and second-generation T cell engagers, Revitope used its deep knowledge of the mechanism of action of immune-based drugs as well ...